[1]
S. Abere, B. Oyan, M. Koofreh-Ada, A. Dan-Jumbo, and H. Omunakwe, “A Study to Assess the Efficacy of the Sofosbuvir/Daclatasvir Combination as a Pan-genotypic Treatment for Hepatitis C without HCV Genotype Determination: https://doi.org/10.60787/NMJ-64-1-240”, Niger Med J, vol. 64, no. 1, p. 136, May 2023.